The Exchange

Commentary and Observations from
the Medical Front Lines

Allergy/Immunology

<a href='/the-exchange/universal-influenza-vaccine-begins-phase-i-clinical-trials'>Universal Influenza Vaccine Begins Phase I Clinical Trials </a>

Universal Influenza Vaccine Begins Phase I Clinical Trials

The National Institutes of Health have begun the first clinical trial of an innovative universal influenza vaccine candidate. A Phase I trial will examine the vaccine’s safety and tolerability as well as its ability to induce an immune response in 53 healthy volunteers. The experimental vaccine, known as H1ssF_3928, was developed by scientists at the National Institute of Allergy and Infectious Diseases. more >

Found in: Allergy/Immunology, Health Policy and Trends, Public Health

Development Widget